Chronic urticaria: Diagnosis and management

被引:30
作者
Khan, David A. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Div Allergy & Immunol, Dept Internal Med, Dallas, TX 75390 USA
关键词
Alternative agents; antihistamines; autoimmune; chronic urticaria; diagnosis; etiology; idiopathic; physical urticaria; tests; treatment;
D O I
10.2500/aap.2008.29.3151
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Chronic urticaria (CU) is a common condition faced by the practicing allergist. There is a considerable degree of variation in the evaluation of patients with CU. The intent of this article is to provide the practicing allergist with all appropriate, evidence-based strategy for diagnosis and initial management of patients with CU. A review was peformed of pertinent literature of CU pertaining to its natural history, impact oil quality of life, subtypes, utility of diagnostic tests, and initial treatment recommendations. The reported duration of CU varies based oil the nature of the referring center; however, physical urticarias persist longer than idiopathic CU. CU has adverse effects oil quality of life and is comparable with other chronic diseases. Idiopathic urticaria, autoimmune CU, and physical urticarias are the most common types of CU, A detailed history is the best diagnostic tool in determining all etiology of CU and routine laboratory tests are of little value in the evaluation of CU patients. Antihistamines, particularly first-generation antihistamines, are the preferred initial treatment for CU and higher doses may be required for adequate control. Several alternative agents exist for patients who have antilhistamine-resistant CU. A detailed history is the best tool for diagnosing the etiology of CU although most patients will not have a specific etiology found. The ultimate goal should be to control urticaria to reduce its impact oil the quality of life of the patient, minimize adverse effects of medications, and eliminate chronic or frequent oral corticosteroids.
引用
收藏
页码:439 / 446
页数:8
相关论文
共 28 条
[1]   Chronic unremitting urticaria: is the use of antihistamines above the licensed dose effective? A preliminary study of cetirizine at licensed and above-licensed doses [J].
Asero, R. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (01) :34-38
[2]   Allergy diagnostic testing: An updated practice parameter [J].
Bernstein, I. Leonard ;
Li, James T. ;
Bernstein, David I. ;
Hamilton, Robert ;
Spector, Sheldon L. ;
Tan, Ricardo ;
Sicherer, Scott ;
Golden, David B. K. ;
Khan, David A. ;
Nicklas, Richard A. ;
Portnoy, Jay M. ;
Blessing-Moore, Joann ;
Cox, Linda ;
Lang, David M. ;
Oppenheimer, John ;
Randolph, Christopher C. ;
Schuller, Diane E. ;
Tilles, Stephen A. ;
Wallace, Dana V. ;
Levetin, Estelle ;
Weber, Richard .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (03) :S1-S148
[3]  
BOGUNIEWICZ M, 2008, CHRONIC URTICURIA AU
[4]   Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome [J].
Davis, MDP ;
Brewer, JD .
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (02) :183-+
[5]  
DELORE P, 1956, J Med Lyon, V37, P497
[6]   Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes [J].
Fukunaga, A ;
Bito, T ;
Tsuru, K ;
Oohashi, A ;
Yu, XJ ;
Ichihashi, M ;
Nishigori, C ;
Horikawa, T .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (02) :397-402
[7]  
Gaig P, 2000, J INVEST ALLERG CLIN, V10, P342
[8]   Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition [J].
Goldbach-Mansky, Raphaela ;
Dailey, Natalie J. ;
Canna, Scott W. ;
Gelabert, Ana ;
Jones, Janet ;
Rubin, Benjamin I. ;
Kim, H. Jeffrey ;
Brewer, Carmen ;
Zalewski, Christopher ;
Wiggs, Edythe ;
Hill, Suvimol ;
Turner, Maria L. ;
Karp, Barbara I. ;
Aksentijevich, Ivona ;
Pucino, Frank ;
Penzak, Scott R. ;
Haverkamp, Margje H. ;
Stein, Leonard ;
Adams, Barbara S. ;
Moore, Terry L. ;
Fuhlbrigge, Robert C. ;
Shaham, Bracha ;
Jarvis, James N. ;
O'Neil, Kathleen ;
Vehe, Richard K. ;
Beitz, Laurie O. ;
Gardner, Gregory ;
Hannan, William P. ;
Warren, Robert W. ;
Horn, William ;
Cole, Joe L. ;
Paul, Scott M. ;
Hawkins, Philip N. ;
Pham, Tuyet Hang ;
Snyder, Christopher ;
Wesley, Robert A. ;
Hoffmann, Steven C. ;
Holland, Steven M. ;
Butman, John A. ;
Kastner, Daniel L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (06) :581-592
[9]   A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects [J].
Grant, JA ;
Riethuisen, JM ;
Moulaert, B ;
DeVos, C .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2002, 88 (02) :190-197
[10]   Increasing the dose of cetirizine may lead to better control of chronic idiopathic urticaria: an open study of 21 patients [J].
Kameyoshi, Y. ;
Tanaka, T. ;
Mihara, S. ;
Takahagi, S. ;
Niimi, N. ;
Hide, M. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 157 (04) :803-804